Correlation Between Singular Genomics and Bluejay Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Singular Genomics and Bluejay Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singular Genomics and Bluejay Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Singular Genomics Systems and Bluejay Diagnostics, you can compare the effects of market volatilities on Singular Genomics and Bluejay Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singular Genomics with a short position of Bluejay Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singular Genomics and Bluejay Diagnostics.

Diversification Opportunities for Singular Genomics and Bluejay Diagnostics

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Singular and Bluejay is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and Bluejay Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluejay Diagnostics and Singular Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singular Genomics Systems are associated (or correlated) with Bluejay Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluejay Diagnostics has no effect on the direction of Singular Genomics i.e., Singular Genomics and Bluejay Diagnostics go up and down completely randomly.

Pair Corralation between Singular Genomics and Bluejay Diagnostics

Given the investment horizon of 90 days Singular Genomics Systems is expected to generate 0.63 times more return on investment than Bluejay Diagnostics. However, Singular Genomics Systems is 1.59 times less risky than Bluejay Diagnostics. It trades about 0.2 of its potential returns per unit of risk. Bluejay Diagnostics is currently generating about 0.02 per unit of risk. If you would invest  1,332  in Singular Genomics Systems on August 28, 2024 and sell it today you would earn a total of  805.00  from holding Singular Genomics Systems or generate 60.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Singular Genomics Systems  vs.  Bluejay Diagnostics

 Performance 
       Timeline  
Singular Genomics Systems 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Singular Genomics Systems are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak forward indicators, Singular Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Bluejay Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Singular Genomics and Bluejay Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Singular Genomics and Bluejay Diagnostics

The main advantage of trading using opposite Singular Genomics and Bluejay Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singular Genomics position performs unexpectedly, Bluejay Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluejay Diagnostics will offset losses from the drop in Bluejay Diagnostics' long position.
The idea behind Singular Genomics Systems and Bluejay Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments